Viking Therapeutics (VKTX) is one of several pharma companies racing to break up the weight loss drug duopoly currently held by Ozempic-maker Novo Nordisk (NVO) and Eli Lilly (LLY), the producer of Zepbound. Read more…Read More
Tag Archives: Ozempic
People taking the drug behind Novo Nordisk’s (NVO) popular Ozempic were found to report suicidal thoughts at a higher rate than people taking other drugs, according to a new study published Tuesday by JAMA Network Open. Read more…Read More
A new study that found evidence of a higher rate of suicidal thoughts among patients taking Novo Nordisk A/S’s popular weight-loss and diabetes drugs is adding to a debate among doctors about the drugs’ safety…Read More
Novo Nordisk’s blockbuster drug Ozempic may offer yet another health benefit: helping to curb overdoses.Read more…Read More
Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify on Capitol Hill Tuesday.Read More
‘Stop ripping us off’: Ozempic producer CEO in hot seat in congressional hearingRead More
The chief executive of the company behind Ozempic and Wegovy blamed insurers and middlemen for the high costs of weight-loss drugs in the U.S. during a congressional testimony on Tuesday. Why it matters: Lars Fruergaard Jørgensen, who leads drug manufacturer Novo Nordisk, passed along accountability for access to these medications while being questioned about his […]
Ozempic doctor recommendation by Aude Bandini, Jean-Philippe Drouin-Chartier, Pierre-Marie David and Rémi Rabasa-Lhoret, The Conversation Credit: Pixabay/CC0 Public Domain The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the […]
The CEO of Novo Nordisk is defending the high cost of Ozempic and Wegovy in America, saying the blockbuster drugs are ultimately saving taxpayers money on obesity-related costs.Read More
Novo Nordisk, Europe’s largest company by market cap thanks to its wildly popular weight-loss drugs, managed just a small increase in second-quarter profits as it builds out the capacity to make the products…Read More